CASºÅ²éѯ
¡¡¡¡¡¡
»¯¹¤²úÆ·
¡¡¡¡¡¡
»¯Ñ§½á¹¹ËÑË÷
¡¡¡¡¡¡
»¯Ñ§¹¤¾ß
¡¡¡¡¡¡
»¯Ñ§ÍøÖ·µ¼º½
ΣÏÕ»¯Ñ§Æ·Ãû¼
msds²éѯ
¡¡¡¡¡¡
VIP²úÆ·¹ºÂò
»¯¹¤²úÆ·
»¯Ñ§Æ·²éѯ
ÎÒµÄÊÔ¼Á¿â²éѯ
msds²éѯ
»¯Ñ§½á¹¹²éѯ
ËÑ Ë÷
ËÑË÷ÉèÖÃ
ʹÓðïÖú
CASºÅ²éѯ
>
»¯¹¤²úÆ·
ÈÈÃÅËÑË÷»¯Ñ§Æ·×î¶àÖ»ÏÔʾǰ20Ìõ£¬Çëµã»÷¡°ËÑË÷»¯Ñ§Æ·¡±²é¿´ËùÓнá¹û
CASµÇ¼ºÅ
ÖÐÎÄÃû
Ó¢ÎÄÃû
·Ö×ӽṹʽ
·Ö×Óʽ
ÏêÇé
¹©Ó¦ÉÌ
761-65-9
N,N-¶þ¶¡»ù¼×õ£°·
N,N-Dibutylformamide;
Dibutylformamide;
N,N-Di-n-butylformamide;
N,N-Dibutylformamide;
NSC 404525
C9H19NO
ÏêÇé
¹©Ó¦ÉÌ
ÈÈÃÅËѹؼü´Ê:
afimoxifene
BB003
Ethyl dodecyl ether
chapa
¶þ ÒìÇèËáõ¥
C6H9FN4O
coffea
1,3-?t???¡¤?¨¬¨ª¨¦
Nocrac
Cluster
¼×»ù ÂÈ ±ûÍé
tinn
Zinc alloy
benzoyl benzoate
ßÁà¤-1-æf
ketoxime
Ethyldimethylamine
Lich2ch3
EC 321€
EC 111
EC 1119
EC 3217
Methylammonium Chloride
¶þ·úÑǼ׻ù
Ë«·ÓA¶þ
DL-Leucic
Îý CAS NO
»Ç°·¼ä à×à¤ÄÆ
N-¶¡»ù¶Ô¼×±½»Çõ£°·
¶¡õ¥ cas
4,4-¶þ¼×Ñõ»ùÁª±½
3,5,7-Èý¼×»ù½ð¸ÕÍé°·
N -ÒÒõ£°ëÈéÌÇ°·
°±»ù ¹è ÒÒÏ©»ù
±ûͪ»ù ±ûͪ
N-[[[2-(Èý¼×Ñõ¹è»ù)ÒÒ»ù]±½»ù]¼×»ù]-1,2-ÒÒ¶þ°·
±½°· ÒÒëæ
±½ ÒÒ°·
¦Å ¹ÈçÞ´¼
c21h21p